VC firm
JSL Health Capital
Also known as JSL Health Capital Fund I Q, JSL Health Capital Fund I, L.P., JSL Health Capital Fund I-Q, L.P., JSL Health Capital Fund II, L.P.
- Investor type
- VC
- Investing status
- Activeas of 2026-09-18Source (opens in a new tab)
- Headquarters
- FAIRFAX, VA, United States
- Founded
- 2020
- Assets under management
- $175MForm ADV private fund GAV, as of 2026-05-06Source (opens in a new tab)
- Latest fund size
- $40.7MSEC amount sold, as of 2020-08-21Source (opens in a new tab)
- Funds
- 13
- Legal name
- JSL HEALTH CAPITAL MANAGEMENT, LLC
Claim, correct or request removal
Record updated 29 September 2026
About
Healthcare is being transformed by software, data and AI. We back the companies leading this convergence to build a healthier tomorrow.
Investment approach
- Thesis
- We invest in late seed and growth-stage healthcare companies leveraging AI, data, and software to transform the world's most important industry.Source (opens in a new tab)
- Investing status notes
- We invest in late seed and growth-stage healthcare companies leveraging AI, data, and software to transform the world's most important industry.
Funds
- JSL Health Capital Fund II, L.P.
- Vintage 2025Main fund
- JSL Health Capital Fund I-Q, L.P.
- Vintage 2021Main fund
- JSL Health Capital Fund I, L.P.
- $40.7MVintage 2020, Main fund, SEC amount sold
- RIS AIV MASTER LP
- Main fund
- JSL DECART.AI COINVEST, L.P.
- SPV
- JSL HEALTH CAPITAL OPPORTUNITY FUND A, L.P.
- Opportunity
- JSL BICYCLE COINVEST, L.P.
- SPV
- JSL ONMED COINVEST, L.P.
- SPV
- JSL XAIRA COINVEST, L.P.
- SPV
- JSL HEALTH CAPITAL OPPORTUNITY FUND, L.P.
- Opportunity
- JSL HEALTH CAPITAL FUND II, LP
- Main fund
- JSL PRECISIONNEURO, A SERIES OF JSL HEALTH CAPITAL SPV, LLC
- SPV
- More funds
- 1 more recorded
SEC registration
- Registered adviser
- JSL HEALTH CAPITAL MANAGEMENT, LLC
- CRD number
- 311005 (opens in a new tab)
- SEC file number
- 802-119859
- Registration
- Exempt reporting adviser
- Regulatory AUM
- $175Mas of 2026-05-06
- Private funds reported
- 12
- SEC CIK
- 1821645, 1858183, 2084006
Loading relationship preview